Emerging treatment options
2006 Jan
Tillmann HC
Efficacy and immunogenicity of novel erythropoietic agents and conventional rhEPO in rates with renal insufficiency.
Kidney Int. 2006 Jan;69(1):60-7
2005 Oct
Lippin Y, et al.
Human erythropoietin gene therapy for patients with chronic renal failure.
Blood. 2005 Oct 1;106(7):2280-6. Epub 2005 Mar 29
2006 Sep
Stead R, et al.
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.
Blood. 2006 Sep 15;108(6):1830-4. Epub 2006 May 23
![]()
Be the first to know
Subscribe to the latest publications, news and event announcements


